BioSpace News Archive

Protagonist Therapeutics, Inc. reported that on September 15, 2020, it issued an inducement award to Matthew Gosling, the Company’s recently hired Executive Vice President and General Counsel, in accordance with the terms of Mr. Gosling’s employment offer letter.

As the pandemic continues to grip the US, the nation’s top emergency physicians will gather virtually next month.

Metacrine, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, announced the pricing of its initial public offering of 6,540,000 shares of its common stock at a public offering price of $13.00 per share.

Benefits offered by safety prefilled syringes, such as more cost-effective processing, ease of use, and elimination of dosing error, and new innovations are major factors that are estimated to propel the safety prefilled syringe system market.

Need to confirm a pregnancy is crucial in animal breeding. It is important to know which ones are getting pregnant and which ones are not in order to determine what the next steps could be.

Cell lines are a one of the key tools that are used for studying and researching the normal biochemistry and physiology of the cells.

Kronos Bio, Inc., a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription, today announced that the company has appointed Elena Ridloff, CFA, to its Board of Directors, where she will serve as Chair of the Audit Committee

The U.S. Navy awarded Science Applications International Corp. a single-award, cost-plus fixed fee task order worth approximately $78 million to provide support services for mobility platform integration for the Expeditionary Department at the Naval Surface Warfare Center in Crane, Indiana.

Sunshine Biopharma Inc. today announced that it has received the first tranche of $250,000 as part of a committed minimum financing of $2 Million with RB Capital Partners Inc.

7D Surgical, a Toronto based medical device company developing advanced optical and machine-vision technologies for surgical navigation, announced today the completion of its recent financing round.